DexCom, Inc. vs Logitech International SA — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Logitech International SA trades at $104.61 (market cap $14.96B). The key difference: DexCom, Inc. is far larger — about 2.3× Logitech International SA's market cap, and Logitech International SA pays a 1.64% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | LOGI | |
|---|---|---|
Market Cap | $33.79B | $14.96B |
Sector | Health | Technology |
52-Week High | $89.53 | $126.69 |
52-Week Low | $54.84 | $85.84 |
Enterprise Value | $33.24B | $13.30B |
Dividend Yield | — | 1.64% |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →